Edaravone containing isoindoline nitroxides for the potential treatment of cardiovascular ischaemia
Edaravone containing isoindoline nitroxides for the potential treatment of cardiovascular ischaemia
复制标题
含有异吲哚啉氮氧化物的依达拉奉可用于治疗心血管缺血
作者:
James R. Walker;K. Fairfull‐Smith;K. Anzai;Shannen Lau;P. White;P. Scammells;S. Bottle
A novel antioxidant for the potential treatment of ischaemia was designed by incorporating an isoindoline nitroxide into the framework of the free radical scavenger edaravone. 5-(3-Methyl-pyrazol-5-ol-1-yl)-1,1,3,3-tetramethylisoindolin-2-yloxyl 7 was prepared by N-arylation of 3-methyl-5-pyrazolone with 5-iodo-1,1,3,3-tetramethylisoindoline-2-yloxyl 8 in the presence of catalytic copper(I)iodide. Evaluation of 7, its methoxyamine derivative 10 and 5-carboxy-1,1,3,3-tetramethylisoindolin-2-yloxyl (CTMIO) against edaravone 1 in ischaemic rat atrial cardiomyocytes revealed significant decreases in cell death after prolonged ischaemia for each agent; however the protective effect of the novel antioxidant 7 (showing greater than 85% reduction in cell death at 100 μM) was significantly enhanced over that of edaravone 1 alone. Furthermore, the activity for 7 was found to be equal to or greater than the potent cardioprotective agent N6-cyclopentyladenosine (CPA). The methoxyamine adduct 10 and edaravone 1 showed no difference between the extent of reduction in cell death whilst CTMIO had only a modest protective effect.
登录
查看更多内容
影响因子:
7.4
作者:
A. Samuni;W. Degraff;J. Cook;M. Krishna;A. Russo;James B. Mitchell
通讯作者:
A. Samuni;W. Degraff;J. Cook;M. Krishna;A. Russo;James B. Mitchell
影响因子:
3.5
作者:
R. Schubert;Laura R. Erker;C. Barlow;H. Yakushiji;D. Larson;A. Russo;James B. Mitchell;A. Wynshaw-Boris
通讯作者:
R. Schubert;Laura R. Erker;C. Barlow;H. Yakushiji;D. Larson;A. Russo;James B. Mitchell;A. Wynshaw-Boris
影响因子:
5.2
作者:
Yin, JJ;Buchwald, SL
通讯作者:
Buchwald, SL
影响因子:
15
作者:
Strieter, ER;Blackmond, DG;Buchwald, SL
通讯作者:
Buchwald, SL